Pfizer has been working on an experimental oral at-home treatment for Covid-19 may be available by the end of the year. The drug is part of a class of medicines called protease inhibitors and works by inhibiting an...
Read More
As many people were predicting, given the typical amount of time that the current Covid-19 vaccines are good for, the CEO of Pfizer has stated that people will probably need to get a booster shot 12 months after being...
Along with the rest of the economy, the pharma industry took a significant hit when the pandemic started. The concern, internally, was how this was going to impact drug prescriptions. Would it be necessary to adjust money spent on...
In a move to help speed up vaccine distribution, and to help defray the cost of providing the vaccine that providers are shouldering, the Biden administration has announced that it will double the amount that Medicare pays out...
A potentially positive outcome from the pandemic is the push in Congress to permanently continue the ability of Medicare patients to use telehealth which has become more widespread over the past year. There are two main sticking points; the...
The United Kingdom will begin “human trial” studies, the first in the world, to discover how much Covid-19 virus it takes to infect a healthy individual. This study will also attempt to understand how the Covid-19 virus impacts people....